Patent Baristas

Does Patent Reform Need Congressional Action?
The Coalition for Patent Fairness (CPF) has put out a memo trying to debunk what it sees as the myth that patent reform no longer requires congressional action.  From CPF:   “The Court’s ability to effect needed changes is limited because it is restricted by the language Congress enacted more than [...]

Ireland Overhauls Patent Rules
Ireland has overhauled its patenting rules to make patent applications more user-friendly and the awarding of patents more in line with US and European standards. The new changes include removing legal impediments to the online delivery of Patent Office services. The Office website already offers a range of online interactive services on [...]

Patenting Genes
WAMU Radio Station (88.5 FM) hosted a segment with Rebecca Roberts on patenting  gene-related products. The biotechnology industry says these patents are necessary to spur innovation. Opponents say they actually stifle science. We examine the intersection of cutting-edge genetic research and intellectual property. Guests included Hans Sauer, Associate General Counsel for Intellectual Property, Biotechnology [...]

University of Missouri v. Professor: Round 2
Earlier, the university filed a lawsuit in federal district court against chemical engineering professor Galen Suppes to regain rights to his research relating to renewable energy.  Now, a federal judge has dismissed the lawsuit ruling that federal patent law does not apply in the case. The university says that [...]

Evolving IP Marketplace
The Federal Trade Commission held the fourth in its series of hearings on the Evolving IP Marketplace. This set of hearings will explore the emergence of new business models in the market for intellectual property, strategies for buying, selling and licensing patents and the role of secondary markets. Discussions covered some of the [...]

Vaya con dios, Genentech
Swiss pharmaceutical company Roche is going to pay $46.8 billion in cash to buy the 44 percent of biotech leader Genentech that it doesn’t already own.  The deal values Genentech at more than $100 billion.  Fortunately, one of Roche’s big products is the tranquilizer Valium.  Genentech’s Avastin, a treatment for various types [...]

Therapies for Ignored Diseases
Last week, the Bill and Melinda Gates Foundation gave Collaborative Drug Discovery (CDD) a $1.9 million grant to help tuberculosis scientists to collaborate to discover new cures for TB, a disease that is resurgent in the 3rd world.   The company provides web-based software that organizes preclinical research data to enable scientists to [...]

R.I.P. Heller
The San Francisco law firm Heller Ehrman will formally vote today to dissolve, chloroforming a law firm that survived earthquakes, a depression, wars and social upheavals but was unable to compete in a new global economy. An overview of “What have we learned from this collapse of a century old, over $500-million in revenue [...]